Loading...

A safe and flowable regenerative solution!

StemVive® is a minimally manipulated allograft specifically designed to be an increased flowable by removing its Extracellular Matrix during processing from post-Cesarean umbilical cord, amniotic materials, and placental birth tissue. The amniotic connective tissue matrix includes elements such as: growth factors, lipids, proteins, carbohydrates, and other nutrients. These elements can help protect, cushion, lubricate, reduce inflammation, and assist the body in the healing and regeneration process. Through our groundbreaking proprietary processing system we are able to protect and preserve high levels of donor stem cells and viability per unit even after cryopreservation.
Clean & Effective Process
As a regenerative medical therapeutic, StemVive® augments the body’s own restorative mechanism. Physician and patient-reported outcomes regarding StemVive® include accelerated injury healing, significant pain relief, and rebuilding of injured tissue, bone, and even nerves. The unique biologic structure of amniotic tissue in StemVive® make it an ideal choice for homologous clinical use.
Supplement Healing
“StemVive® has proven to be an entirely safe and effective therapeutic Standard Of Care for hundreds of medical practitioners throughout the United States,” according to Dr. Eliott Spencer, Ph.D., founder, owner, and Chief Scientific Officer for Utah Cord Bank. “Our unwavering compliance with FDA rules on laboratory procedures and cryopreservation has enabled us to sustain one of the highest safety records, a distinguished achievement in the U.S. biologics industry.”
Donor Eligibility
Healthy, pre-screened Utah mothers donate the placental birth tissue at the time of Cesarean Sections. Donors are pre-screened via comprehensive medical and prenatal evaluations to determine eligibility, in accordance with FDA and Current Good Tissue Practice (CGTP) guidelines.
Healthy, pre-screened Utah mothers donate the placental birth tissue at the time of Cesarean Sections. Donors are pre-screened via comprehensive medical and prenatal evaluations to determine eligibility, in accordance with FDA and Current Good Tissue Practice (CGTP) guidelines.
Figure 1:
The number of live nucleated cells/ml immediately following thawing. There is a significant difference between the number of live nucleated cells for StemVive® versus our competitor’s product. (**p=0.0029)
Figure 2:
The percent of live nucleated cells/ml immediately following thawing. There is a significant difference between the percent of nucleated cells for StemVive® versus our competitor’s product. (**p=0.0011)

Contact

Call Us
888-295-1093
Address
8765 South Sandy Parkway, Ste 110
Sandy, UT 84070
All the fields are required